Expert Highlights Data that Led to the Approval of Fedratinib in Myelofibrosis

Press/Media: Press / Media

PeriodAug 22 2019

Media coverage

1

Media coverage

  • TitleExpert Highlights Data that Led to the Approval of Fedratinib in Myelofibrosis
    Media name/outletTargeted Oncology
    CountryUnited States
    Date8/22/19
    PersonsRuben Mesa